AstraZeneca and MSD's Lynparza approved in the EU for p

AstraZeneca and MSD's Lynparza approved in the EU for prostate cancer

Related Keywords

China , Japan , Dave Fredrickson , Noel Clarke , Manchester Christie Salford , Eliav Barr , Astrazeneca , Manchester University , Research Laboratories , European Union , European Commission , Head Of Global Clinical Development , Medicinal Products , Human Use , Neurological Surgeon , Urological Oncology , Salford Royal Hospitals , Executive Vice President , Oncology Business Unit , Senior Vice President , Global Clinical Development , Chief Medical Officer , Functional Assessment , Cancer Therapy Prostate , New Drug Application , Priority Review , Prescription Drug User Fee Act ,